MapLight Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business UpdateGlobeNewswire Nov 16, 2026, 12:15:00 PM
MapLight Therapeutics to Participate in Upcoming Investor ConferenceGlobeNewswire Nov 9, 2026, 9:05:00 PM
MapLight Therapeutics Celebrates Co-Founder Dr. Karl Deisseroth on Receipt of 2026 Nobel Prize in Physiology or Medicine for the Development of OptogeneticsGlobeNewswire Oct 6, 2026, 11:00:00 AM
MapLight Therapeutics to Participate in Upcoming Investor ConferenceGlobeNewswire Sep 9, 2026, 11:00:00 AM